THE NIH GUIDELINES FOR RESEARCH INVOLVING RECOMBINANT DNA MOLECULES
The NIH Guidelines outline procedures involving use of recombinant DNA and describe the roles, responsibilities, and relationships among the principal investigator (PI), the Institutional Biosafety Committee (rDNA review committee), and the National Institutes of Health (NIH).
The NIH Guidelines also contain helpful information regarding physical and biological containment guidelines and risk assessment (categorized into Risk Group 1, 2, 3, or 4).
Compliance with the NIH Guidelines is a necessity due to federal NIH funding received by UT Arlington. All projects involving recombinant DNA techniques conducted at or sponsored by an institution that receives NIH funds for projects involving such techniques must comply with the NIH Guidelines. Noncompliance may result in: (i) suspension, limitation, or termination of NIH funds for all recombinant DNA research at the institution, or (ii) a requirement for prior NIH approval of any or all recombinant DNA projects at the institution.
UT ARLINGTON'S POLICY & PROCEDURES FOR RESEARCH INVOLVING RECOMBINANT DNA
UT Arlington’s Policy & Procedures for Research Involving Recombinant DNA Molecules define and describe in great detail: covered recombinant DNA experiments, applicability, responsibilities of the UT Arlington IBC and PIs, training requirements, containment guidelines, and the IBC’s research review process and procedures.
BIOSAFETY IN MICROBIOLOGICAL AND BIOMEDICAL LABORATORIES, 5TH EDITION
The Centers for Disease Control (CDC’s) Biosafety in Microbiological and Biomedical Laboratories, 5th edition (the “BMBL”) establishes a code of practice for biosafety in laboratories - one that all members of the research and laboratory community can utilize to safeguard themselves and their colleagues, and to protect the public health and environment.
The BMBL contains helpful information regarding risk assessment, laboratory safety standards, containment guidelines, and categorization of biological agents/material into containment levels (referred to as Biosafety Level 1, 2, 3, or 4). These classifications are based on infectivity, severity of disease, transmissibility, and the nature of the work being conducted.